rs17635492
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs17635492(A;A) |
Make rs17635492(A;T) |
Make rs17635492(T;T) |
Reference | GRCh38 38.1/141 |
Chromosome | 6 |
Position | 117450114 |
is a | snp |
is | mentioned by |
dbSNP | rs17635492 |
dbSNP (classic) | rs17635492 |
ClinGen | rs17635492 |
ebi | rs17635492 |
HLI | rs17635492 |
Exac | rs17635492 |
Gnomad | rs17635492 |
Varsome | rs17635492 |
LitVar | rs17635492 |
Map | rs17635492 |
PheGenI | rs17635492 |
Biobank | rs17635492 |
1000 genomes | rs17635492 |
hgdp | rs17635492 |
ensembl | rs17635492 |
geneview | rs17635492 |
scholar | rs17635492 |
rs17635492 | |
pharmgkb | rs17635492 |
gwascentral | rs17635492 |
openSNP | rs17635492 |
23andMe | rs17635492 |
SNPshot | rs17635492 |
SNPdbe | rs17635492 |
MSV3d | rs17635492 |
GWAS Ctlg | rs17635492 |
GMAF | 0.01882 |
Max Magnitude | 0 |
? | (A;A) (A;T) (T;T) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 23478653] |
Trait | Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer |
Title | A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy. |
Risk Allele | |
P-val | 4E-7 |
Odds Ratio | 7.60 [3.50-16.70] |